Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.
The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.
Publications found:
68
Sort by:
Licensing Deals in Pharmaceuticals 2019-2023
US$ 3,995.00
... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...
September 2023
1200 pages
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2023
US$ 3,995.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
September 2023
700 pages
Royalty Rates in Pharmaceuticals and Biotechnology Deals
US$ 3,995.00
... including the technology licensed, royalty rates, license fees, upfront and milestone payments. DESCRIPTION The Global Royalty Rate Trends in Pharma ... licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate ...
September 2023
500 pages
Collaboration Deals in Biotechnology 2019-2023
US$ 3,995.00
SUMMARY Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2023 DESCRIPTION Collab...
September 2023
1000 pages
Distribution Deals in Diagnostics 2016 to 2023
US$ 3,995.00
SUMMARY Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2023 DESCRIPTION Distribut...
September 2023
250 pages
Licensing Deals in Biotechnology 2019-2023
US$ 3,995.00
SUMMARY Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2023Licensing Deals in Biot...
September 2023
1000 pages
Distribution Deals in Medical Devices 2016 to 2023
US$ 3,995.00
SUMMARY Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2023 DESCRIPTION Distr...
September 2023
250 pages
Global Animal Health Partnering Terms and Agreements 2017 to 2023
US$ 3,995.00
... access to actual Animal Health contracts entered into by leading biopharma companies Identify most active Animal Health dealmakers since 2014 Insight into terms included in a Animal Health partnering agreement, with real ...
March 2023
150 pages
Global Big Pharma Partnering Terms and Agreements 2016-2023
US$ 3,995.00
... an agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive listing of the top 25 most active companies including Pfizer, Sanofi, Abbott, GlaxoSmithKline, Johnson & Johnson ...
March 2023
2000 pages
Global Biotech Partnering Terms and Agreements 2018-2023
US$ 3,995.00
SUMMARY Global Biotech Partnering Terms and Agreements 2014 to 2019 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals DESCRIPTION Global Biotech Partnering Terms and Agreements 2014 ...
March 2023
3800 pages
Global Medical Device Partnering Terms and Agreements 2016-2023
US$ 3,995.00
SUMMARY Global Medical Device Partnering Terms and Agreements 2014-2019 report provides a detailed understanding and analysis of how and why companies enter Medical Device partnering deals DESCRIPTION Global Medical Device Partnering Terms and Agreements 2014 ...
March 2023
900 pages
Global Pharmaceutical Partnering Terms and Agreements 2018-2023
US$ 3,995.00
SUMMARY Global Pharmaceutical Partnering Terms and Agreements 2014 to 2019 report provides a detailed understanding and analysis of how and why companies enter Pharmaceutical partnering deals DESCRIPTION Global Pharmaceutical Partnering Terms and Agreements 2014 ...
March 2023
4000 pages
Global Specialty Pharmaceutical Partnering Terms and Agreements 2016-2023
US$ 3,995.00
SUMMARY Global Specialty Pharmaceutical Partnering Terms and Agreements 2014 to 2019 report provides a detailed understanding and analysis of how and why companies enter Specialty Pharmaceutical partnering deals DESCRIPTION Global Specialty Pharmaceutical Partnering Terms and Agreements 2014 ...
March 2023
750 pages
